L Kangas Selected Research

Neoplasms (Cancer)

3/2006	Evaluation of inhibitors for 17beta-hydroxysteroid dehydrogenase type 1 in vivo in immunodeficient mice inoculated with MCF-7 cells stably expressing the recombinant human enzyme.
2/2000	Selective estrogenic effects of a novel triphenylethylene compound, FC1271a, on bone, cholesterol level, and reproductive tissues in intact and ovariectomized rats.
1/2000	Hydroxymatairesinol, a novel enterolactone precursor with antitumor properties from coniferous tree (Picea abies).

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

L Kangas Research Topics

Disease

3	Neoplasms (Cancer) 03/2006 - 01/2000
2	Bone Resorption 01/2014 - 06/2007
2	Breast Neoplasms (Breast Cancer) 03/2006 - 02/2000
2	Inflammation (Inflammations) 12/2001 - 07/2001
1	Atrophy 05/2014
1	Dyspareunia 05/2014
1	Postmenopausal Osteoporosis 01/2014
1	Osteosarcoma (Osteogenic Sarcoma) 06/2007
1	Endometrial Neoplasms (Endometrial Cancer) 06/2007

Drug/Important Bio-Agent (IBA)

3	Estrogens (Estrogen)FDA Link 05/2014 - 02/2000
3	OspemifeneIBA 05/2014 - 06/2007
2	Selective Estrogen Receptor Modulators (SERM)IBA 01/2014 - 06/2007
2	Raloxifene Hydrochloride (Evista)FDA Link 01/2014 - 06/2007
1	droloxifeneIBA 01/2014
1	collagen type I trimeric cross-linked peptideIBA 06/2007
1	OsteoprotegerinIBA 06/2007
1	Parathyroid Hormone (Parathormone)IBA 06/2007
1	Tamoxifen FDA LinkGeneric 06/2007
1	3 (or 17)-beta-hydroxysteroid dehydrogenaseIBA 03/2006
1	Polyglactin 910IBA 12/2001
1	PolydioxanoneIBA 12/2001
1	EthisorbIBA 12/2001
1	CollagenIBA 07/2001
1	anthraceneIBA 01/2000

Therapy/Procedure

1	Absorbable Gelatin Sponge 07/2001